J-Pharma Co.,Ltd.
J-Pharma Selected for Funding under AMED's Global Research and Development Support Project for the Treatment of Intractable/Rare Diseases
Earlier from J-pharma Co.,ltd
- J-Pharma Enters into Non-Binding Term Sheet with European Biotech Company for JPH034
- Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
- Notice Regarding Issuance of New Shares as Restricted Stock Compensation to Directors and Executive Officers
- Matters Relating to Business Plans and Growth Potential